29Jul
National Retailer Pulls CBD Products From Shelves in Response to FDA Warning to Product Manufacturer
On Monday, July 22, the U.S. Food and Drug Administration (FDA) took a rare and significant step in issuing a warning letter to Curaleaf Holdings, Inc. (Curaleaf), one of the country’s larger producers of CBD-based products, regarding Curaleaf’s...
By:
Manatt, Phelps & Phillips, LLP
Related
In the midst of a global Pandemic that is devastating to the health of our community and to our econ...
Read More >
Seyfarth Synopsis: The New Jersey bill that aims to push gig-economy workers and other independent c...
Read More >
Corporate Pay Equity - When competing for top talent, equal pay matters. Boards of directors are i...
Read More >
On Thursday, January 30, members from Verrill's Employment & Labor group, as well as some from the E...
Read More >
The California Supreme Court has ruled that a former employee’s retaliation or discrimination claim...
Read More >
El 29 de marzo de 2019, el gobierno de México lanzó la Prueba Piloto de la Incorporación de los Trab...
Read More >